A new generation of interactive formulation development platforms can leave trial and error in the formulation process in the past.
Jason Hansell
Advertisement
Jason Hansell is Junior Applications Technologist at Colorcon Inc. (PA, USA).
Articles by Jason Hansell
Pharmaceutical Technology Europe
Based on formulation simplicity and blinding capability, hard gelatin capsules are preferrable compared with other oral solid dosage forms, including tablets, in the early clinical phases of drug development.
Advertisement
Latest Updated Articles
The New Digital Era for Formulation DevelopmentOctober 15th 2023
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5